06:01 PM EDT, 05/21/2024 (MT Newswires) -- Benjamin L Palleiko, Director, CEO, on May 17, 2024, sold 21,959 shares in Kalvista Pharmaceuticals ( KALV ) for $258,337. Following the Form 4 filing with the SEC, Palleiko has control over a total of 216,387 shares of the company, with 216,387 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1348911/000141588924014001/xslF345X03/form4-05212024_090551.xml